Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjogren Syndrome: A Potential Association with Therapies

被引:24
|
作者
Conigliaro, Paola [1 ]
Triggianese, Paola [1 ]
Draghessi, Gianluca [2 ]
Canofari, Claudia [1 ]
Aloe, Gianluca [2 ]
Chimenti, Maria Sole [1 ]
Valeri, Claudia [2 ]
Nucci, Carlo [2 ]
Perricone, Roberto [1 ]
Cesareo, Massimo [2 ]
机构
[1] Univ Roma Tor Vergata, Dept Med Sistemi, Rheumatol Allergol & Clin Immunol Unit, Viale Oxford 81, IT-00133 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med & Surg, Ophthalmol Unit, Rome, Italy
关键词
Hydroxychloroquine; Retina; Systemic lupus erythematosus; Sjogren syndrome; Spectral-domain optical coherence tomography; STANDARD AUTOMATED PERIMETRY; OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; OCULAR MANIFESTATIONS; HYDROXYCHLOROQUINE; GLAUCOMA; DISEASE; CLASSIFICATION; AUTOANTIBODIES; CHLOROQUINE;
D O I
10.1159/000488950
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Retinal involvement in systemic lupus erythematosus (SLE) and Sjogren syndrome (SS) may be subclinical and thus underdiagnosed. Objectives: We aimed at evaluating morphological and functional visual abnormalities in a cohort of SLE and SS patients in the absence of an overt clinical visual impairment. We also investigated potential associations between retinal disorders and disease activity, organ involvement, and treatment with steroid and/or hydroxychloroquine. Methods: The study comprised 42 SLE and 36 primary SS patients and 76 healthy controls (HC). Ophthalmological examination, standard automated perimetry, spectral-domain optical coherence tomography, and fundus perimetry were performed. Results: Retinal thickness of the posterior pole was not different between SLE and HC groups, but it was reduced in the SS group compared with both the HC and the SLE group. In SLE and SS patients, mean defect and pattern standard deviation by standard automated perimetry were higher than in HC. Visual field index values were lower in both SLE and SS patients than in HC. SLE patients with nephritis displayed increased mean defect and pattern standard deviation and reduced visual field index values compared to patients without nephritis. In SLE and SS patients, fundus perimetry differential sensitivity was reduced, and mean defect values were higher than in HC. Disturbances in fundus perimetry in the SLE group were more prevalent in steroid-naive patients and in SS patients who received a cumulative hydroxychloroquine dose >1,000 g. Conclusions: Functional eye impairment was demonstrated in SLE patients, possibly associated with kidney involvement. In SLE, corticosteroids might exert a protective role. Morphological alterations and functional impairment were detected in SS patients, which may be linked to hydroxychloroquine toxicity. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [41] Detection of anti-type VII collagen antibody in Sjogren's syndrome lupus erythematosus overlap syndrome with transient bullous systemic lupus erythematosus
    Fujii, K
    Fujimoto, W
    Ueda, M
    Makino, E
    Arata, J
    BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (02) : 302 - 306
  • [42] COMPLEX IMMUNOPHENOTYPING STRATIFIES PATIENTS WITH PRIMARY SJOGREN'S SYNDROME, SYSTEMIC LUPUS ERYTHEMATOSUS AND SECONDARY SJOGREN'S SYNDROME ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS INTO DISTINCT CLINICALLY RELEVANT GROUPS WITH POTENTIAL THERAPEUTIC IMPLICATIONS
    Thompson, N.
    Gandhi, A.
    Radmmore, R.
    Gupta, V.
    Robinson, G.
    Martin-Gutierrez, L.
    Isenberg, D.
    Jury, E.
    Ciurtin, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 239 - 240
  • [43] Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome
    Matorras, R.
    Ocerin, I.
    Unamuno, M.
    Nieto, A.
    Peiro, E.
    Burgos, J.
    Exposito, A.
    LUPUS, 2007, 16 (09) : 736 - 740
  • [44] Update on infections and vaccinations in systemic lupus erythematosus and Sjogren's syndrome
    Pasoto, Sandra G.
    Ribeiro, Ana C. M.
    Bonfa, Eloisa
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (05) : 528 - 537
  • [45] Citrullinated antibodies in systemic lupus erythematosus and primary Sjogren's syndrome
    Hullo, D.
    Szoeke, L.
    Szollosl, I
    Balog, A.
    Sonkodi, G.
    Lele, K.
    Torok, E.
    Kovacs, L.
    Zeher, M.
    Sipka, S.
    Pokorny, G.
    2ND EUROPEAN CONGRESS OF IMMUNOLOGY (ECI), 2009, : 309 - +
  • [46] Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjogren's syndrome
    Tsunemi, Y
    Tada, Y
    Saeki, H
    Ihn, H
    Tamaki, K
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (05) : 483 - 485
  • [47] Neurologic Complications of Systemic Lupus Erythematosus, Sjogren Syndrome, and Rheumatoid Arthritis
    Bhattacharyya, Shamik
    Helfgott, Simon M.
    SEMINARS IN NEUROLOGY, 2014, 34 (04) : 425 - 436
  • [48] Predicting Sjogren's Syndrome At Diagnosis of Systemic Lupus Erythematosus.
    Hernandez-Molina, Gabriela
    Zamora-Legoff, Tatiana
    Romero-Diaz, Juanita
    Alberto Nunez-Alvarez, Carlos
    Cardenas-Velazquez, Francisco
    Hernandez-Hernandez, Carlos
    Luisa Calderillo, Maria
    Marroquin, Martha
    Recillas-Gispert, Claudia
    Avila-Casado, Carmen
    Sanchez-Guerrero, Jorge
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S950 - S951
  • [49] Autoimmune thyroid disease in systemic lupus erythematosus and Sjogren's syndrome
    Scofield, RH
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (03) : 321 - 330
  • [50] Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjogren's syndrome
    Fujisawa, Tomomi
    Seishima, Mariko
    Suzuki, Satoko
    Shibuya, Yoshinao
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB64 - AB64